Evidence map›Paper›PMID 42587135›Full record

ArticleNature biotechnology2026

Simultaneous single-cell profiling of chromatin, transcriptome and surface markers with OneCell CUT&Tag captures epigenomic reprogramming.

Anna Schwager, Eve Moutaux, Adeline Durand, Alexandra Van Keymeulen, Amélie Viaene, Mélanie Miranda, Louisa Hadj Abed, Simon Besson-Girard, Marion Lambault, Délia Dupré and 16 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Anna Schwager *CNRS UMR3244, Institut Curie, PSL University, Paris, France.ORCID http://orcid.org/0000-0001-6830-149X
Eve Moutaux *CNRS UMR3244, Institut Curie, PSL University, Paris, France.
Adeline DurandCNRS UMR3244, Institut Curie, PSL University, Paris, France.ORCID http://orcid.org/0000-0002-7423-2504
Alexandra Van KeymeulenLaboratory of Stem Cells and Cancer, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Amélie ViaeneLaboratory of Stem Cells and Cancer, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Mélanie MirandaCNRS UMR3244, Institut Curie, PSL University, Paris, France.
Louisa Hadj AbedCNRS UMR3244, Institut Curie, PSL University, Paris, France.
Simon Besson-GirardCNRS UMR3244, Institut Curie, PSL University, Paris, France.ORCID http://orcid.org/0000-0003-1194-5256
Marion LambaultCNRS UMR3244, Institut Curie, PSL University, Paris, France.
Délia DupréCNRS UMR3244, Institut Curie, PSL University, Paris, France.
Grégoire JouaultCNRS UMR3244, Institut Curie, PSL University, Paris, France.ORCID http://orcid.org/0009-0003-0581-8768
Melissa SaichiCNRS UMR3244, Institut Curie, PSL University, Paris, France.
Juliette BertorelloCNRS UMR3244, Institut Curie, PSL University, Paris, France.
Simon DumasInstitut Curie, Université, PSL, Sorbonne Université, CNRS UMR168, Physic of the Cell and Cancer, Paris, France.ORCID http://orcid.org/0000-0002-9636-7178
Mathias SchwartzCNRS UMR3244, Institut Curie, PSL University, Paris, France.ORCID http://orcid.org/0000-0002-7998-6110
Marthe LaisnéCNRS UMR3244, Institut Curie, PSL University, Paris, France.
Justine MarsolierCNRS UMR3244, Institut Curie, PSL University, Paris, France.
Manuel GuthmannCNRS/INSERM UMR3215/U934, Institut Curie, PSL University, Paris, France.
Lorraine BonnevilleCNRS/INSERM UMR3215/U934, Institut Curie, PSL University, Paris, France.
Urvashi ChitnavisCNRS/INSERM UMR3215/U934, Institut Curie, PSL University, Paris, France.ORCID http://orcid.org/0000-0002-0837-3341
Déborah Bourc'hisCNRS/INSERM UMR3215/U934, Institut Curie, PSL University, Paris, France.ORCID http://orcid.org/0000-0001-9499-7291
Elisabetta MarangoniTranslational Research Department, Institut Curie, PSL University, Paris, France.
Nicolas ServantSingle-Cell Initiative, Institut Curie, PSL University, Paris, France.
Cédric BlanpainLaboratory of Stem Cells and Cancer, Université Libre de Bruxelles (ULB), Brussels, Belgium.ORCID http://orcid.org/0000-0002-4028-4322
Leïla PeriéSingle-Cell Initiative, Institut Curie, PSL University, Paris, France.ORCID http://orcid.org/0000-0003-0798-4498
Céline VallotCNRS UMR3244, Institut Curie, PSL University, Paris, France. celine.vallot@curie.fr.ORCID http://orcid.org/0000-0003-1601-2359

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 948528
6 · The paper itself

Abstract

Simultaneous mapping of chromatin states and transcriptomes in rare cell populations is challenging, as most methods require thousands of cells and are limited in their ability to capture multiple molecular layers accurately within the same cell. Here we introduce OneCell CUT&Tag, a method that provides matched high-resolution epigenome, full-transcriptome and surface marker quantification from every cell, with input as low as one cell, without relying on computational aggregation into metacells. Using this approach, we uncover epigenomic priming of basal cells in the mammary gland and capture the dynamics of basal-to-luminal transdifferentiation, suggesting that epigenomic and transcriptional remodeling do not occur in complete synchrony during cell-fate conversion. Adaptable to diverse samples and tissues, this method also reveals the role of H3K27me3 in shaping zygotic expression programs. By matching multiple layers of molecular information within individual cells, OneCell CUT&Tag reveals how complementary regulatory layers shape cellular identity and state, enabling the study of rare biological samples in development and disease.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.